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D. Dolce1, S. Campana1, C. Braggion1, G. Taccetti1. 1CF Center, Meyer Hospital,
Florence, Italy
Chronic Pa infection in CF patients is preceded by an intermittent infection. Tran-
siently colonized patients can undergo successful eradication treatment therefore a
careful monitoring of early stages of Pa lung colonization is important. The aim of
the present study was to evaluate antibodies against Pa in patients with intermittent
infection. Patients attending the CF Centre of Florence were enrolled over a 4-year
period (2007–2010). According to Leeds criteria 138 patients were divided into
4 groups: 38 (27.5%) patients had never been infected with Pa, 29 (21%) were
free of Pa, 24 (17.4%) were intermittently infected and 8 (6%) were chronically
infected during the study period. Serum samples were collected during regular
check-ups. A total of 393 sera were analysed using ELISA method to test the
presence of IgG against Pa lipopolysaccharide (LPS) (U/ml). Low IgG levels
(mean) were found in never-colonized patients and in Pa-free patients (3.6U/ml
and 4.9U/ml respectively). The IgG level in intermittently colonized patients was
7.6U/ml. In the chronically colonized group the IgG level was higher (21.5U/ml)
and statistically different from all the other groups (p< 0.001). The differences
among the mean IgG level of each group versus the remaining groups was also
statistically signiﬁcant (p< 0.001). A cut-off level for speciﬁc IgG anti-Pa LPS
values was determined in this group of patients using a ROC curve. A value
of 4.8U/ml was the most sensitive and speciﬁc for identifying patients with
intermittent infection. In conclusion, the study showed that evaluation of speciﬁc
anti-LPS antibody response can be useful for monitoring the early phases of Pa
infection.
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Objective: P. aeruginosa (P.a.) is an opportunist ﬂagellated Gram-negative bac-
terium present in the lung of up to 80% of cystic ﬁbrosis (CF) patients, causing
hypersecretion of airway mucus and airway obstruction. The mechanisms by which
P.a. induces mucus hypersecretion are incompletely understood. In the present study
we aimed to determine whether and how P.a. ﬂagellin leads to mucus hypersecretion.
Methods: (i) Human airway epithelial cells (NCI-H292) were infected in vitro for
24 h with a wild-type (WT) P.a. (PAK strain) or with its ﬂagellin-deﬁcient mutant
(DFliC). The amounts of airway mucins (both at mRNA and protein levels), as well
as of the pro-inﬂammatory interleukin-8 (IL-8), were quantiﬁed in vitro. (ii) WT,
TLR4−/−, TLR5−/−, MyD88−/− and TLR4/5−/− mice were infected intranasally
with either WT PAK or with DFliC and the amount of lung mucins was determined
by RT-PCR and Alcian blue staining.
Results: (i) Infection with WT PAK, but not with the DFliC, lead to: (a) production
of a signiﬁcantly high level of MUC5AC protein and mRNA; and (b) an increase
in the level of IL-8; (ii) treatment of cells with P.a. ﬂagellin induced MUC5AC
expression through a ERK1/2 dependent pathway; (iii) TLR5 silencing by siRNA
reduced ﬂagellin-induced MUC5AC expression; (iv) similar levels of mucin mRNAs
were detected in the lung of WT, TLR4−/− and TLR5−/− mice infected with WT
PAK. However, signiﬁcantly lower levels of mucins were detected in the lung of
MyD88−/− and TLR4/5−/−.
Conclusion: Our results demonstrate that ﬂagellin plays a key role in P.a-induced
airway mucus hypersecretion through a MyD88, TLR5 and ERK1/2 dependent
mechanism.
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Introduction and Aims: Some transmissible strains of P. aeruginosa are more
virulent than non-transmissible strains and stimulate a heightened immunological
response. The aim of this study was to compare IgG titre against P. aeruginosa
antigens in clinically stable adult CF patients colonised with either transmissible
(n = 20 patients) or non-transmissible strains (n = 20 patients).
Methods: Serum samples from clinically stable CF patients with chronic P. aerug-
inosa infection were assayed by ELISA for IgG against P. aeruginosa antigens.
Antibody response was correlated with other clinical and demographic parameters:
CRP, white cell and neutrophil count, BMI, FEV1 and age.
Results: There was no difference detected between groups for any of the clinical
and demographic parameters and groups were well matched. Furthermore, there was
no signiﬁcant difference in IgG response against P. aeruginosa antigens between
the groups (p = 0.64). Therefore, results from both groups were combined for
further statistical analysis. Positive correlations were detected between IgG and
all parameters except age (p = 0.189). These correlations were highly signiﬁcant
between IgG and CRP (p = 0.002), neutrophil (p = 0.008) and white cell count
(p = 0.005). A weaker correlation was observed between IgG and FEV1 and BMI
(p-values = 0.03 and 0.04 respectively).
Conclusion: During periods of clinical stability, CF patients infected with transmis-
sible P. aeruginosa do not show a heightened IgG response against speciﬁc P. aerug-
inosa antigens, when compared with patients colonised with non-transmissible
strains. Antibody levels correlate with other systemic markers of inﬂammation.
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Pseudomonas aeruginosa represents the most important pathogen in cystic ﬁbrosis
(CF). CF patients produce non-protective anti-pseudomonal antibodies, but the role
of CD4+ T cell responses to Pseudomonas remains unclear. Novel T helper cell
subsets, Th17 and Th22 cells, have important roles in defense but may also enhance
tissue damage. We aimed to deﬁne what T helper cell responses to Pseudomonas
are present in healthy adults as a prelude to determining the role of cellular
pseudomonal immunity in CF.
Monocyte-derived dendritic cells (DCs) were stimulated with live Pseudomonas
aeruginosa strain PA103. Autologous CD4+CD45RO+T cells were co-cultured with
activated DCs for 6-days. T cell phenotype was analysed via ﬂow cytometry and
ELISA.
We found that monocyte-derived DCs from healthy adults are readily activated
by PA103. Co-culture of autologous memory CD4+ T cells with Pseudomonas-
activated DCs resulted in CD4+ T cells primarily producing IFN-g with other
T cells subsets expressing both IFN-g and IL-22, or IL-22 alone. The memory
IL-22-producing T cells responding to Pseudomonas predominantly expressed
CCR6 and RORgt, but were CCR4 and CCR10 negative. No Th17 response to
Pseudomonas was evident. The response was MHC-restricted and antigen-speciﬁc
T cell proliferation was demonstrated.
These data demonstrate that healthy individuals possess Th1 and Th22 memory
responses to Pseudomonas which may have important implications for the patho-
genesis of chronic Pseudomonas infection in cystic ﬁbrosis. Further work is planned
to ascertain the role these cellular responses play in protection versus pathogenesis
in Pseudomonal pulmonary infection.
